Sara Hestrin-Lerner
Sara Hestrin-Lerner is a renowned medical researcher and immunologist known for her significant contributions to the field of immunology. She has made notable advancements in understanding the human immune system and its response to various diseases.
Early Life and Education[edit | edit source]
Sara Hestrin-Lerner was born and raised in California, United States. She developed an interest in biology at a young age, which led her to pursue a Bachelor's degree in Biological Sciences from the University of California, Berkeley. She then went on to earn a Ph.D. in Immunology from the Stanford University School of Medicine.
Career[edit | edit source]
After completing her Ph.D., Hestrin-Lerner joined the National Institutes of Health (NIH) as a postdoctoral fellow. At NIH, she conducted research on the human immune system, specifically focusing on the role of T cells in immune response.
Hestrin-Lerner later moved to the University of California, Los Angeles (UCLA), where she currently serves as a research scientist. At UCLA, she continues her research on the immune system, with a particular emphasis on autoimmune diseases and cancer immunology.
Contributions to Immunology[edit | edit source]
Hestrin-Lerner's research has significantly advanced our understanding of the human immune system. Her work has shed light on the role of T cells in immune response, and has led to new insights into the mechanisms of autoimmune diseases and cancer.
Her research has also contributed to the development of new immunotherapies for treating diseases such as rheumatoid arthritis and cancer. These therapies work by harnessing the power of the immune system to fight disease, and have the potential to revolutionize the way we treat many serious illnesses.
Recognition[edit | edit source]
In recognition of her contributions to the field of immunology, Hestrin-Lerner has received numerous awards and honors. These include the American Association of Immunologists' Young Investigator Award and the National Institutes of Health's Outstanding Investigator Award.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
